Concepedia

Ross D. Ballantine

RD

Statistics

Publications

7

Citations

138

H-Index

7

Active since

2018

Affiliations

Queen's University Belfast(Current)

Stranmillis University College

University of Hong Kong

Leiden University

Hong Kong University of Science and Technology

Ross D. Ballantine is an author at Queen's University Belfast specializing in drug design, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2018–2024

7

Publications

7

Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and <i>in vivo</i> efficacy

Karol Al Ayed, Ross D. Ballantine, Michael Hoekstra et al. · Chemical Science · 2022 · 30 citations · Full text

, , +11

Rational design of new cyclic analogues of the antimicrobial lipopeptide tridecaptin A<sub>1</sub>

Ross D. Ballantine, Yong‐Xin Li, Pei‐Yuan Qian et al. · Chemical Communications · 2018 · 24 citations · Full text

, , +17

Tridecaptin-inspired antimicrobial peptides with activity against multidrug-resistant Gram-negative bacteria

Ross D. Ballantine, Conor E. McCallion, Elie Nassour et al. · MedChemComm · 2019 · 24 citations · Full text

, , +17

Linearization of the Brevicidine and Laterocidine Lipopeptides Yields Analogues That Retain Full Antibacterial Activity

Ross D. Ballantine, Karol Al Ayed, Samantha J. Bann et al. · Journal of Medicinal Chemistry · 2023 · 19 citations · Full text

, , +17

A Chemical-Intervention Strategy To Circumvent Peptide Hydrolysis by <scp>d</scp>-Stereoselective Peptidases

Samantha J. Bann, Ross D. Ballantine, Conor E. McCallion et al. · Journal of Medicinal Chemistry · 2019 · 16 citations · Full text

, , +16

1–5 of 7